Virtus Investment Advisers »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.6k 4.0k 2.15
2024-03-31 $7.1k 4.0k 1.79
2023-12-31 $5.7k 4.0k 1.41

More positions owned by Virtus Investment Advisers

Icici Bank Adr (IBN)
Virtus Etf Tr Ii Duff & Phelps Cl (VCLN)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Microsoft Corporation (MSFT)
Taylor Morrison Hom (TMHC)
CommVault Systems (CVLT)
Veracyte (VCYT)
Apple (AAPL)
Barrett Business Services (BBSI)
Kirby Corporation (KEX)
Knife River Corp Common Stock (KNF)
NVIDIA Corporation (NVDA)
Adma Biologics (ADMA)
Nmi Hldgs Inc cl a (NMIH)
Zeta Global Holdings Corp Cl A (ZETA)

View all positions for Virtus Investment Advisers

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
D. E. Shaw & Co
Capstone Investment Advisors
CSS
Boothbay Fund Management
Elequin Capital
Warberg Asset Management
Palisade Capital Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Citigroup
Jpmorgan Chase & Co
UBS Group
Bank of America Corporation

View all funds holding Sarepta Therapeutics note 1.500% 11/1